Genetic Variant Testing by NGS
Our Testing Panels
Senior Care Labs catches infections early, reduces outbreaks, and avoids unnecessary hospitalizations. We offer comprehensive testing for over 52 different pathogens, including blood, urinary, respiratory (RPP), state of the art advanced wound care, and genetic testing, utilizing state-of-the-art PCR/PGX technology, which has become the GOLD STAR standard of Medicare & Medicaid.
Genetic Variant
Testing
Identify inherited mutations that increase the risk of disease. Our advanced genetic testing panels help detect predispositions to conditions like cancer, dementia, heart disease, and more—empowering early intervention and personalized care.
Infectious Disease Testing
Fast, accurate detection of bacterial, viral, and fungal pathogens using PCR technology. We offer 24–48 hour turnaround for panels including respiratory, wound, urinary, STI, and more—plus antibiotic resistance profiling to guide treatment.
Toxicology
Testing
Monitor prescription drug compliance, detect misuse, and prevent harmful interactions. Our comprehensive toxicology panels test for over 70 substances, supporting safe medication management and legal protection for providers.
General Health
Testing
Comprehensive lab panels that evaluate blood, urine, and organ function for early detection of common health issues. Ideal for routine screenings, wellness checks, and chronic condition monitoring in long-term care settings.
What we also offer
Genetic Variant Testing by NGS
Cardiomyopathy NGS Panel designed to detect multiple cardiomyopathy conditions
Cardiomyopathy Genetic Testing
Cardiomyopathies are a group of conditions that affect the heart muscle, leading to mechanical and/or electrical dysfunction. These disorders can impair the heart’s ability to pump blood effectively and may increase the risk of heart failure or sudden cardiac death.
While some cardiomyopathies are acquired, many have a genetic origin. Identifying these inherited forms through genetic testing is critical, as they often present without clear symptoms until serious complications occur.
Common Inherited Cardiomyopathy Conditions:
Hypertrophic Cardiomyopathy (HCM)
Dilated Cardiomyopathy (DCM)
Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
Left Ventricular Noncompaction (LVNC)
Why Test for Cardiomyopathies?
Genetic testing plays a vital role in:
Confirming or clarifying a diagnosis
Informing treatment decisions
Identifying at-risk family members
Guiding lifestyle and medication choices
Reducing the risk of sudden cardiac events
Comprehensive cardiomyopathy panels from Senior Care Labs allow clinicians to evaluate a broad spectrum of genetic mutations associated with these life-threatening conditions — enabling early detection, personalized care, and peace of mind.
Cardiopulmonary NGS Panel for early diagnosis to improve long-term health.
Cardiopulmonary Genetic Testing
Cardiopulmonary syndromes are conditions that affect both the heart and lungs, two organs that work in close coordination. Dysfunction in one system often impacts the other — making early, accurate diagnosis essential.
For example:
-Heart failure can impair oxygen exchange in the lungs, leading to shortness of breath
-Lung disease can strain the heart, forcing it to work harder to circulate oxygen-rich blood
What the Panel Covers
The Cardiopulmonary NGS Panel analyzes 236 genes linked to a wide range of genetic heart and lung conditions. It provides clinicians with deep insight into underlying causes that may not be evident through imaging or routine testing.
Benefits of Genetic Testing
-Early Detection & Prevention:
Identify high-risk patients sooner and initiate personalized interventions that support long-term heart and lung health.
-Improved Treatment Planning:
Genetic insights can uncover associated complications, allowing for earlier treatment and better outcomes.
-Access to Clinical Trials:
A confirmed genetic diagnosis may qualify patients for targeted therapies or investigational treatments not otherwise available.
Senior Care Labs offers this advanced cardiopulmonary panel as part of our precision diagnostics program — helping care teams protect their most vulnerable residents with faster answers and more confident care.
Cancer Genetic Testing (CGx Panel)
Identify hereditary cancer risks. Act early. Improve outcomes.
Senior Care Labs offers a Next-Generation Sequencing (NGS) CGx panel that screens for inherited genetic mutations linked to various cancers. This blood-based test targets the most clinically relevant genes associated with cancers of the breast, colon, ovaries, uterus, pancreas, prostate, and skin, including melanoma.
Commonly ordered by oncologists and primary care physicians, this panel is especially valuable for patients with a family history of cancer or other known risk factors.
What We Test For
Our multi-gene panel analyzes high-impact mutations such as:
-BRCA1 and BRCA2 – linked to increased risk of breast, ovarian, prostate, and skin cancers
-MLH1, MSH2, MSH6, PMS2, and EPCAM – associated with Lynch Syndrome, which increases the risk of colorectal, endometrial, and other gastrointestinal cancers
Benefits of CGx Testing
-Early Identification of Risk
Detects genetic predispositions before symptoms arise, allowing for proactive screening and preventive care.
-Peace of Mind or Early Action
A negative result offers reassurance, while a positive result empowers patients and care teams to make informed medical decisions.
-Guided Screening Protocols
Test results can guide clinicians on which cancer screenings to prioritize based on genetic risk.
-Family Impact
Results may inform other family members of their own cancer risks and prompt early testing or surveillance.
Why Genetics Matter
While most genetic variants are harmless, 5–10% of all cancers are caused by inherited mutations. Knowing a patient’s genetic status can significantly influence:
-Surveillance plans
-Medication choices
-Preventive surgeries
-Lifestyle recommendations
Who Should Be Tested?
According to the American Cancer Society, genetic cancer testing is recommended for individuals with:
-Multiple relatives with the same or related cancers
-Cancer diagnosed at unusually young ages (e.g., colorectal cancer under 25)
-One individual with multiple types of cancer (e.g., breast and ovarian)
-Cancer in both paired organs (e.g., both breasts, kidneys, or ovaries)
-Male breast cancer in the family
-Cancers occurring across multiple generations
-Childhood cancers in more than one sibling
Senior Care Labs provides easy access to this vital testing through Medicare- and Medicaid-covered services with simple blood collection, fast turnaround, and full clinical support.
Eye Disorder NGS Panel
Genetic insights to guide diagnosis, treatment, and family risk management.
The Eye Disorder NGS Panel from Senior Care Labs analyzes 81 genes associated with a wide range of inherited eye diseases. These comprehensive panels are designed to support the diagnosis and management of conditions affecting the retina, optic nerve, cornea, ocular structure, eye movement, as well as glaucoma, cataracts, and myopia.
What We Test For:
Non-Syndromic Retinal Diseases
These conditions are typically confined to the eye and include:
-Retinitis Pigmentosa
-Leber Congenital Amaurosis
-Macular Dystrophy
-Stargardt Disease
-Cone-Rod Dystrophy
-Exudative Vitreoretinopathy
-Achromatopsia
Syndromic Retinal Diseases
These disorders involve the eyes and other organ systems:
-Usher Syndrome
-Joubert Syndrome
-Senior-Løken Syndrome
-Stickler Syndrome
-Bardet-Biedl Syndrome
Why Genetic Testing for Eye Disorders Matters
Clarifies Diagnosis
Helps distinguish between clinically similar eye conditions that may require different treatments.
Informs Treatment Options
Identifies candidates for gene-specific therapies and experimental treatments.
Guides Genetic Counseling
Supports family planning and helps identify at-risk relatives.
Tracks Disease Variability
Reveals how different mutations in the same gene—or across different genes—can cause variations in onset, progression, and severity of vision loss, even within the same family.
Understanding the genetic cause of an eye disorder allows clinicians to move beyond symptom management and toward precision-based interventions — improving outcomes and enhancing quality of life for patients and their families.
Eye Disorder NGS Panel
Genetic insights to guide diagnosis, treatment, and family risk management.
The Eye Disorder NGS Panel from Senior Care Labs analyzes 81 genes associated with a wide range of inherited eye diseases. These comprehensive panels are designed to support the diagnosis and management of conditions affecting the retina, optic nerve, cornea, ocular structure, eye movement, as well as glaucoma, cataracts, and myopia.
What We Test For:
Non-Syndromic Retinal Diseases
These conditions are typically confined to the eye and include:
-Retinitis Pigmentosa
-Leber Congenital Amaurosis
-Macular Dystrophy
-Stargardt Disease
-Cone-Rod Dystrophy
-Exudative Vitreoretinopathy
-Achromatopsia
Syndromic Retinal Diseases
These disorders involve the eyes and other organ systems:
-Usher Syndrome
-Joubert Syndrome
-Senior-Løken Syndrome
-Stickler Syndrome
-Bardet-Biedl Syndrome
Why Genetic Testing for Eye Disorders Matters
Clarifies Diagnosis
Helps distinguish between clinically similar eye conditions that may require different treatments.
Informs Treatment Options
Identifies candidates for gene-specific therapies and experimental treatments.
Guides Genetic Counseling
Supports family planning and helps identify at-risk relatives.
Tracks Disease Variability
Reveals how different mutations in the same gene—or across different genes—can cause variations in onset, progression, and severity of vision loss, even within the same family.
Understanding the genetic cause of an eye disorder allows clinicians to move beyond symptom management and toward precision-based interventions — improving outcomes and enhancing quality of life for patients and their families.
Pharmacogenetics (PGx) NGS Panel
Personalized prescribing to prevent adverse drug reactions.
The Pharmacogenetic (PGx) Panel from Senior Care Labs uses next-generation sequencing (NGS) to analyze how a patient's unique genetic makeup affects their response to medications. By identifying genetic variations that impact drug metabolism, PGx testing empowers providers to make safer, more effective prescribing decisions.
Why PGx Testing Matters
Genetics account for 20–90% of variability in how individuals absorb, metabolize, and respond to medications. The CYP450 family of enzymes, which metabolizes a wide range of drugs, differs from person to person. Based on their CYP450 genotype, individuals may be classified as:
- Poor metabolizers (risk of drug buildup and toxicity)
- Intermediate metabolizers
- Extensive (normal) metabolizers
- Rapid or ultra-rapid metabolizers (risk of underdosing or treatment failure)
The Impact of Adverse Drug Reactions (ADRs)
Adverse drug reactions cause approximately 770,000 injuries and deaths annually in the U.S. Many of these could be avoided with personalized dosing and drug selection based on PGx insights.
How It Helps Providers
Our PGx panel helps clinicians:
- Predict how a patient will respond to specific medications
- Avoid dangerous side effects and drug interactions
- Eliminate trial-and-error prescribing
- Optimize dosing for maximum therapeutic effect
- Improve long-term outcomes and reduce hospitalizations
Panel Features
- Non-invasive sample collection (buccal swab or blood)
- Rapid turnaround times
- Covered by Medicare, Medicaid, and most insurance
- Full clinical guidance and support available
Pharmacogenetic testing is especially valuable in fields like primary care, psychiatry, cardiology, pain management, and geriatrics, where medication regimens are complex and the risks of ADRs are high.
Senior Care Labs makes it easy to integrate PGx testing into your patient care model — helping you deliver truly personalized medicine.
Primary Immunodeficiency (PID) NGS Panel
Clarify diagnoses. Distinguish complex immune disorders. Improve care.
The Primary Immunodeficiency NGS Panel from Senior Care Labs is a powerful genetic tool for identifying inherited immune system disorders and distinguishing between diseases with overlapping clinical presentations. This test is especially useful for patients with chronic infections, unexplained inflammation, or autoimmune symptoms that may point to a deeper, genetic cause.
Why It Matters
Autoimmune diseases affect an estimated 3–10% of the population, with varying prevalence across conditions and demographics. These diseases occur when the adaptive immune system mistakenly attacks the body’s own tissues. Many autoimmune conditions are influenced by a complex mix of genetic and environmental factors, though a subset are monogenic and directly traceable to specific gene mutations.
Primary immunodeficiencies (PIDs) are inherited conditions that result in heightened susceptibility to infections and may also predispose patients to:
- Cancer
- Allergies
- Chronic inflammation
- Autoimmune diseases
What This Panel Tests For
Our panel screens for a wide range of immune-related genetic mutations and conditions, including but not limited to:
- Nezelof’s Syndrome
- HIV-related immune suppression markers
- Pneumocystosis susceptibility
- Pancytopenia
- Myelofibrosis
- Other immune dysregulation syndromes
Clinical Value
- Differentiates between clinically similar conditions
- Identifies underlying causes of chronic immune dysfunction
- Aids in earlier diagnosis, especially in complex or unclear presentations
- Supports risk assessment, family counseling, and personalized treatment planning
Senior Care Labs provides this panel using advanced next-generation sequencing (NGS) with a fast turnaround, easy sample collection, and clinical support — helping your care team make faster, more confident decisions for residents with unexplained or persistent immune-related symptoms.
Thyroid Genetics NGS Panel
Identify genetic changes in thyroid function. Reduce unnecessary surgeries.
Each year, nearly 600,000 people in the U.S. undergo fine-needle aspiration (FNA) biopsies to evaluate thyroid nodules. While FNA remains a standard diagnostic tool, 20–25% of biopsy results return as indeterminate, often leading to diagnostic surgeries that may ultimately prove unnecessary.
In fact, up to 60% of these surgeries result in over- or under-treatment—creating avoidable risk, cost, and stress for patients.
A Better Way to Manage Thyroid Nodules
The Thyroid Genetics NGS Panel from Senior Care Labs uses highly sensitive next-generation sequencing (NGS) technology to analyze genetic mutations associated with:
- Hypothyroidism
- Thyroid hormone resistance
- Thyroid cancer risk
By uncovering the molecular profile of a thyroid nodule, this test provides physicians with:
- Clearer diagnostic guidance
- More accurate risk stratification
- Support for non-surgical management pathways when appropriate
Panel Overview
- 45 clinically relevant genes analyzed
- Covers both functional thyroid disorders and thyroid cancer predisposition
- Helps avoid unnecessary surgeries in patients with indeterminate FNA biopsy results
- Ideal for endocrinologists, internists, and general practitioners managing thyroid conditions
Benefits to Patients & Providers
- Improved diagnostic accuracy for ambiguous nodules
- Reduction in avoidable thyroidectomies
- Personalized treatment and follow-up planning
- Covered by Medicare, Medicaid, and most insurance plans
With thyroid disorders on the rise and surgical interventions often misaligned with genetic risk, Senior Care Labs offers providers a powerful tool for precision thyroid care that supports better outcomes and minimizes unnecessary procedures.
Pulmonary NGS Panel
Genetic insights for early diagnosis and long-term lung health.
Pulmonary diseases—commonly referred to as lung or respiratory disorders—can result from environmental exposure, infections, or inherited genetic mutations. While many lung conditions are acquired over time, a subset are genetic in origin and often go undiagnosed until complications arise.
The Pulmonary NGS Panel from Senior Care Labs enables early detection of inherited lung conditions, helping clinicians intervene sooner to preserve lung function and reduce long-term risks.
What We Test For
This panel screens for a broad range of genetic pulmonary conditions, including:
- Cystic Fibrosis – the most common inherited lung disease, affecting mucus clearance in the airways
- Primary Ciliary Dyskinesia (PCD) – impairing lung defense mechanisms
- Tuberous Sclerosis Complex (TSC) – which may involve lung cysts and tumors
- Birt-Hogg-Dubé Syndrome – associated with spontaneous pneumothorax and lung cysts
And many other rare, gene-related pulmonary syndromes
Benefits of Pulmonary Genetic Testing
- Enables early, accurate diagnosis of rare lung conditions
- Allows for personalized monitoring of lung function and complications (e.g., infections, pneumothorax, or end-stage lung disease)
- Supports referral to experimental treatments and clinical trials
- Helps detect extra-pulmonary complications associated with many genetic lung diseases
- Improves long-term prognosis through early initiation of preventive care
Panel Features
- Analysis of key genes associated with hereditary pulmonary disorders
- Non-invasive testing with fast turnaround
- Covered by Medicare, Medicaid, and most private insurance
- Ideal for pulmonologists, genetic counselors, and primary care providers with at-risk patients
Genetic testing is a powerful tool in early detection and disease management. By identifying inherited lung conditions early, Senior Care Labs helps providers deliver proactive, personalized care that safeguards respiratory health before irreversible damage occurs.
Primary Immunodeficiency NGS Panel
Uncover the genetic causes of immune dysfunction and overlapping autoimmune conditions.
Primary immunodeficiencies (PIDs) are inherited disorders that impair the body’s ability to fight infections and regulate immune responses. They often present with symptoms that overlap with autoimmune diseases, chronic inflammation, or even malignancies—making accurate diagnosis both complex and critical.
The PID NGS Panel from Senior Care Labs helps clinicians detect the genetic causes behind persistent or unexplained immune symptoms, especially when clinical presentation is unclear or overlaps with multiple conditions.
Why It Matters
- Autoimmune diseases affect 3–10% of the population, with varied incidence based on disease type and demographic factors.
- While many are complex and multifactorial, a subset of autoimmune conditions are monogenic and directly linked to specific genetic mutations.
- PIDs not only increase susceptibility to infection, but also raise the risk for cancer, autoimmunity, allergic diseases, and chronic inflammation.
What This Panel Helps Diagnose
The panel includes genes linked to numerous immune-related conditions, such as:
- HIV-related immune suppression
- Pneumocystosis
- Nezelof’s Syndrome
- Pancytopenia
- Myelofibrosis
- Other rare and complex immune dysregulation syndromes
Clinical Benefits
- Differentiates between autoimmune, infectious, and inflammatory disorders with similar symptoms
- Supports earlier and more accurate diagnoses
- Improves long-term care planning through personalized risk assessment
- Guides genetic counseling for affected families
- Identifies candidates for targeted therapies or clinical trials
Panel Features
- Covers a wide range of immune system-related genes
- Non-invasive sample collection (buccal swab or blood)
- Fast turnaround with full clinical reporting
- Covered by Medicare, Medicaid, and most major insurance
Senior Care Labs delivers precision diagnostics that help your team move beyond symptom-based assumptions. With our Primary Immunodeficiency NGS Panel, providers can better diagnose, manage, and monitor patients with complex or recurring immune issues.
How it works
3 Simple steps to work with us
1) Book a Consultation Call
Schedule a call with one of our senior medical directors. We’ll introduce our services, learn about your current lab setup, and provide a customized plan for improving diagnostic efficiency. Whether you're under contract or exploring options, we’ll guide you every step of the way.
2) On-Site Collection & Shipping — At No Cost
Our licensed nursing team visits your facility to perform all sample collections — fully equipped and at no charge to you. We handle everything from swabbing to shipping, minimizing staff workload and ensuring high-quality samples with zero disruption to care routines.
3) Rapid Results & Supportive Care
Results are delivered securely within 24–48 hours, with personalized insights from our expert lab team. Need help interpreting results? We offer dedicated clinical support and free genetic counseling, so your staff can make confident, informed care decisions.
100k+
Lab Tests Provided
50+
Facilities Partnered
100%
Satisfaction
10+
Partnered Labs
Frequently Asked Questions
Is there any cost to the facility?
No. There is no cost to your facility for collection, processing, or equipment. We bill insurance directly and handle all logistics ourselves.
Do you provide staff to collect samples?
Yes. We send our own licensed nurses to your facility to handle sample collection and shipping. This allows your team to stay focused on care while we manage the diagnostics.
What is the turnaround time for results?
Results are delivered securely within 24–48 hours for PCR panels and up to 2 weeks for genetic testing, depending on the type of panel ordered.
How do we receive results?
Results are delivered through secure, HIPAA-compliant channels, either via your EHR system, secure email, or our provider portal.
Are your labs certified?
Absolutely. All testing is performed at our CLIA-certified, CAP-accredited laboratory, ensuring accuracy, reliability, and compliance.
What insurances do you accept?
We accept Medicare, Medicaid, and most major private insurance plans. We verify coverage before any testing is performed.
Do you require a contract or long-term commitment?
No. We operate on a flexible, partnership-first model. You can use our services as needed — no long-term contract required.
Do you serve facilities nationwide?
Yes. We currently operate across the United States and can deploy nursing teams or ship kits to your location based on your needs.
What if we already have a lab partner?
No problem. We’ll assess what your current partner does and identify where we can fill gaps or provide better service, especially for specialized genetic or PCR testing your current lab may not offer.
How do I get started?
Click the “Book a Call” button on our website to schedule a consultation with one of our medical directors. We’ll walk you through the next steps and provide everything you need.
Be Part of Our Thriving Network of Senior Care facilities today!
Join a community of dedicated professionals reshaping the future of health With access to unparalleled resources, continuous training, and industry-leading tools, we empower people in your facility to live well everyday!